4 studies found for:
AGS-003
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Enrolling by invitation |
A Rollover Protocol for Subjects Previously Treated With AGS-003
|
||||
| 2 | Recruiting |
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
|
||||
| 3 | Completed |
Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment
|
||||
| 4 | Completed |
Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer
|
† Indicates status has not been verified in more than two years